Japan· JP-2649720N1028
グリチルレチン酸
A enoxolone product containing グリチルレチン酸, registered in Japan by 摩耶堂製薬, on the national reimbursement list. The same ATC class is registered in 2 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Enoxolone is registered in 2 of 19 countries.
Countries holding a registration under ATC D03AX10 (enoxolone), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 1 of them publish a price we can compare per daily dose
Enoxolone · ATC D03AX10
2 / 19 countries
- Belgiumprice
- Japan
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- グリチルレチン酸
- Manufacturer
- 摩耶堂製薬
- Country
- Japan (JP)
- ATC code
- D03AX10
- ATC class
- Enoxolone
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Enoxolone in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f581a24e-e525-4498-965e-2da7c7a38289 GET /v1/drugs/f581a24e-e525-4498-965e-2da7c7a38289?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１％１ｇ",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2649720N1028",
"category": "外用薬",
"price_yen": 8.6,
"generic_name": "グリチルレチン酸",
"product_name_jp": null,
"therapeutic_class": "2649",
"transitional_expiry": null
}See everything about enoxolone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.